Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Neuroinflammation to Treat Alzheimer’s Disease
Alberto Ardura-Fabregat, Erik Boddeke, Antonio Boza‐Serrano, et al.
CNS Drugs (2017) Vol. 31, Iss. 12, pp. 1057-1082
Open Access | Times Cited: 205

Showing 26-50 of 205 citing articles:

Astrocytic ceramide as possible indicator of neuroinflammation
Nienke M. de Wit, Sandra den Hoedt, Pilar Martínez‐Martínez, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 77
New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease
Sun Ah Park, Song Mi Han, Chae Eun Kim
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 4, pp. 556-568
Open Access | Times Cited: 75
A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse
Min Sung Gee, Seung Hwan Son, Seung Ho Jeon, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 75
The Role of Neurovascular System in Neurodegenerative Diseases
Ajmal Ahmad, Vanisha Patel, Jianfeng Xiao, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 11, pp. 4373-4393
Closed Access | Times Cited: 74
Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease
Sofia Toniolo, Arjune Sen, Masud Husain
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9318-9318
Open Access | Times Cited: 71
Deciphering the Potential Neuroprotective Effects of Luteolin against Aβ1–42-Induced Alzheimer’s Disease
Sareer Ahmad, Myeung Hoon Jo, Muhammad Ikram, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9583-9583
Open Access | Times Cited: 69
Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders
Gregory Hook, Thomas Reinheckel, Junjun Ni, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 600-629
Open Access | Times Cited: 62
Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
Zeng-Hui Wei, Jagadish Koya, Sandra E. Reznik
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 60
Extracellular vesicles derived from Porphyromonas gingivalis induce trigeminal nerve-mediated cognitive impairment
Xiaoyang Ma, Yoon-Jung Shin, Jong-Wook Yoo, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 293-303
Open Access | Times Cited: 35
Dual role of nitric oxide in Alzheimer's disease
Ali Azargoonjahromi
Nitric Oxide (2023) Vol. 134-135, pp. 23-37
Closed Access | Times Cited: 32
The Neuroprotective Effects and Therapeutic Potential of the Chalcone Cardamonin for Alzheimer’s Disease
Kimberly Barber, Patricia Mendonca, Karam F. A. Soliman
Brain Sciences (2023) Vol. 13, Iss. 1, pp. 145-145
Open Access | Times Cited: 27
Ketogenic diet alleviates cognitive dysfunction and neuroinflammation in APP/PS1 mice via the Nrf2/HO-1 and NF-κB signaling pathways
Jingwen Jiang, Hong Pan, Fanxia Shen, et al.
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2767-2772
Open Access | Times Cited: 23
The Involvement of Antioxidants in Cognitive Decline and Neurodegeneration: Mens Sana in Corpore Sano
Claudio Nazzi, Alessio Avenanti, Simone Battaglia
Antioxidants (2024) Vol. 13, Iss. 6, pp. 701-701
Open Access | Times Cited: 12
Neuroinflammation of Microglial Regulation in Alzheimer’s Disease: Therapeutic Approaches
Haiyun Chen, Yuhan Zeng, Dan Wang, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1478-1478
Open Access | Times Cited: 11
Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease
Maya Koronyo‐Hamaoui, Julia Sheyn, Eric Y. Hayden, et al.
Brain (2019) Vol. 143, Iss. 1, pp. 336-358
Open Access | Times Cited: 62
The Role of Eicosanoids in Alzheimer’s Disease
Roger G. Biringer
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 14, pp. 2560-2560
Open Access | Times Cited: 58
5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer’s disease
Fang Chen, Arijit Ghosh, Jingran Lin, et al.
Brain Behavior and Immunity (2020) Vol. 88, pp. 844-855
Closed Access | Times Cited: 54
Resveratrol, Metabolic Dysregulation, and Alzheimer’s Disease: Considerations for Neurogenerative Disease
Alex Yang, Ahmed Bagit, Rebecca E. K. MacPherson
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4628-4628
Open Access | Times Cited: 54
Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease
Anurag Kumar Singh, Sachchida Nand, Anand Maurya, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-19
Open Access | Times Cited: 53
Chemical identity and cardiovascular toxicity of hydrophobic organic components in PM2.5
Zenghua Qi, Yanhao Zhang, Zhifeng Chen, et al.
Ecotoxicology and Environmental Safety (2020) Vol. 201, pp. 110827-110827
Closed Access | Times Cited: 52
Toll-like receptors in Alzheimer's disease
Sara Momtazmanesh, George Perry, Nima Rezaei
Journal of Neuroimmunology (2020) Vol. 348, pp. 577362-577362
Closed Access | Times Cited: 51
Dysregulation of Astrocyte–Neuronal Communication in Alzheimer’s Disease
Carmen Nanclares, Andrés M. Baraibar, Alfonso Araque, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7887-7887
Open Access | Times Cited: 47
The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders
João P. Luís, Carlos J. V. Simões, Rui M. M. Brito
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1731-1731
Open Access | Times Cited: 35
Macrophage subsets and their role: co-relation with colony-stimulating factor-1 receptor and clinical relevance
Shivani Yadav, Astik Priya, Diksha R. Borade, et al.
Immunologic Research (2022) Vol. 71, Iss. 2, pp. 130-152
Open Access | Times Cited: 34
Non-invasive Biomarkers for Early Detection of Alzheimer’s Disease: a New-Age Perspective
Niyamat M. A. Chimthanawala, Akash Haria, Sadhana Sathaye
Molecular Neurobiology (2023) Vol. 61, Iss. 1, pp. 212-223
Closed Access | Times Cited: 17

Scroll to top